The province of Quebec is challenging the recent federal Genetic Non-Discrimination Act as unconstitutional, claiming it infringes on the provincial jurisdiction of insurance industry regulation. Yvonne Bombard, at St. Michael’s Hospital, and Bev Heim-Myers, CEO of the Huntington Society of Canada, are pushing back.
Ontario’s agriculture and agri-food sector is strong and growing. However, the demands and challenges the sector is faced with are also growing. In the context of enhancing a socially and environmentally responsible industry, genomics-based innovations and technologies provide significant opportunities to advance Ontario’s agriculture and agri-food sector.
Resulting from the inaugural Canada SynBio 2018 conference and strategic workshop held in March, the Discussion Paper, The Present and Future State of Synthetic Biology in Canada, is now available
The CIM (Canadian Institute of Mining, Metallurgy and Petroleum) convention held in Vancouver May 6-9, 2018 brought together over 5000 participants from the mining industry, with technical presentations across various themes such as rock mechanics, underground mining, and safety among several others. Over the past few years, CIM has included genomics work related to mining in its…
The Network Biology Collaborative Centre (NBCC) at the Lunenfeld-Tanenbaum Research Institute assists scientists with connecting information on genomic and phenotypic variation in health and disease with a functional understanding of how gene products convey biological information and how their alterations drive disease. The Centre provides critical added value to Canada’s genomics enterprise by offering an…
HAPPY DNA DAY! Can you decipher this famous, visionary quote? Hint: Based on one letter amino acid codes. Tweet your answer using #DNADay18 and tagging us @OntarioGenomics ATT ACA CAT ATC AAT AAA ACC CAT GAA AAC ATC GGC GGT GAA TCT ACT ATC AAT AAT TAA GTC GCA ACC ATC TGA AAT AGT TAA…
In 2017, a Nature paper got a lot of attention due to the claim by the Stanford authors that the CRISPR-based gene editing technique may cause widespread genetic damage when used in vivo. The authors have just retracted this paper, after concerns were raised that the proper controls had not been employed.
23andMe CEO Anne Wojcicki has published an Op-ed critique of the position that consumers cannot interpret their own genetic risk scores. Recently, the FDA approved 23andMe’s genetic test for inherited cancer. There was some criticism of this, which Wojcicki compares to the warnings forty years ago that women might not be able to handle the results of those first home pregnancy tests.
Check out our conference page for updates from Canada SynBio 2018 including presentations, highlights and photos from the conference.
-Conference Presentations can be found by clicking on the active links under each session in the SynBio Agenda.
-Conference Highlights can be found in our SynBio Feature.
-Additional Photos from the conference can be found in our SynBio Page and Photo Album.
Major advances in genomics and informatics over the past several years have resulted in individual research projects producing enormous amounts of data. In particular, genomic data from large population and clinical cohorts, coupled with extensive health and lifestyle data, have the potential to generate critical biological insights into human health and novel determinants of disease….